4-(4-Methylpiperazin-1-yl)aniline → N-Methyl-N-(2-{2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-[1,2,4]triazolo[1,5-a]pyridin-8-ylethynyl}-phenyl)-methanesulfonamide
Reaction equation
Cl[C:2]1[N:24]=[C:5]2[C:6]([C:10]#[C:11][C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=3[N:18]([CH3:23])[S:19]([CH3:22])(=[O:21])=[O:20])=[CH:7][CH:8]=[CH:9][N:4]2[N:3]=1.[CH3:25][N:26]1[CH2:31][CH2:30][N:29]([C:32]2[CH:37]=[CH:36][C:35]([NH2:38])=[CH:34][CH:33]=2)[CH2:28][CH2:27]1.C1(P(C2CCCCC2)C2C=CC=CC=2C2C=CC=CC=2P(C2CCCCC2)C2CCCCC2)CCCCC1>>[CH3:23][N:18]([C:13]1[CH:14]=[CH:15][CH:16]=[CH:17][C:12]=1[C:11]#[C:10][C:6]1[C:5]2[N:4]([N:3]=[C:2]([NH:38][C:35]3[CH:34]=[CH:33][C:32]([N:29]4[CH2:28][CH2:27][N:26]([CH3:25])[CH2:31][CH2:30]4)=[CH:37][CH:36]=3)[N:24]=2)[CH:9]=[CH:8][CH:7]=1)[S:19]([CH3:22])(=[O:21])=[O:20]Participants
Reactant 3
Product 1
Procedure
189 d) N-Methyl-N-(2-{2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-[1,2,4]triazolo[1,5-a]pyridin-8-ylethynyl}-phenyl)-methanesulfonamide was prepared from N-[2-(2-chloro-[1,2,4]triazolo[1,5-a]pyridin-8-ylethynyl)-phenyl]-N-methyl-methanesulfonamide (125.0 mg, 0.3464 mmol) and 4-(4-methyl-piperazin-1-yl)-phenylamine (73.0 mg, 0.382 mmol) with 2,2′-bis-dicyclohexylphosphanyl-biphenyl (37.0 mg, 0.0677 mmol) as the ligand in a manner analogous to Example 2d. Product isolated as a yellow foam (0.138 g, 77%). 1H NMR (400 MHz, CDCl3, δ, ppm): 8.40 (d, J=6.6 Hz, 1H), 7.65 (d, J=7.6 Hz, 1H), 7.61 (d, J=7.4 Hz, 1H), 7.55-7.48 (m, 3H), 7.43 (t, J=7.5 Hz, 1H), 7.37 (t, J=7.5 Hz, 1H), 7.00 (d, J=7.7 Hz, 2H), 6.86 (t, J=7.0 Hz, 1H), 6.73 (s, 1H), 3.61 (s, 3H), 3.23-3.16 (m, 7H), 2.63-2.58 (m, 4H), 2.37 (s, 3H). MS=516 (MH)+.
Sources & evidence
- ORD record
- ord-1a7d586e2dc74569898cd0eeef670b6b
- Source dataset
- uspto-grants-2014_01
- Patent number
- US08633173B2
Reaction notes
Loading…